Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative medicines aimed at improving patients' lives. We offer a broad range of medicines for cancer, cardiovascular disease, endocrine disease, inflammatory disease, infectious disease, neurological disease, organ transplantation, psychiatric disease, respiratory disease and skin conditions. The company's mission is to improve people's lives by pioneering novel healthcare solutions.
Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and over-the-counter products. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 130,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.
Novartis Patient Assistance Foundation, Inc.,
Novartis Pharmaceuticals Corporation believes that all Americans deserve access to quality health care, including prescription medicines, health education about their disease or condition, and information on the medicines they take. In the US, Novartis is committed to enhancing access to medicine through various programs, such as the Novartis Patient Assistance Foundation, Inc., an affiliate of Novartis Pharmaceuticals Corporation (PAF). PAF provides assistance to patients experiencing financial hardship who have no third party insurance coverage for their medicines.
Patient Assistance Programs
Novartis Group companies have established patient assistance programs to help patients in need in both developing and developed countries.
In the US, for example, through the Novartis Patient Assistance Foundation, Inc., Novartis has designed a number of assistance programs and offers reimbursement hotlines for patients without prescription drug coverage or experiencing financial hardship.
In 2013, Novartis patient assistance programs in the US provided products worth USD 550 million to more than 96,000 patients in need.
Novartis also supports the Partnership for Prescription Assistance, a single point of access to more than 475 public and private patient assistance programs in the US, including more than 180 programs offered by healthcare companies.
Alcon, our eye care division, helps patients within the US through Alcon Cares, Inc., which provides eye care medication to qualified, low-income individuals at no charge.
Corporate Social Responsibility
Novartis Pharmaceuticals Corporation puts patients first. In 2014, the Novartis Patient Assistance Foundation (PAF) and Institutional PAP (which serves state programs and free clinics) provided free product valued at $169 million dollars to 109,000 patients in need. The Novartis PAF provides assistance to patients experiencing financial hardship who have no third party insurance coverage for their medications and includes many of Novartis' life sustaining/single sourced medications.
Novartis is also committed to assisting patients from around the world. In 2007 their global access-to-medicines programs, valued at USD 937 million, reached 66 million patients. In the developing world, we extend free leprosy and tuberculosis treatment and offer our antimalarial drug Coartem without profit through multilateral institutions and public-private partnerships.
People and Communities
Novartis Pharmaceuticals Corporation is committed to developing meaningful partnerships with non-profit organizations that are dedicated to enhancing quality of life, recognize the interests of their employees, and address significant social issues related to health, education and civic engagement in the communities where Novartis operates. They also contribute financially to support the local community because their employees believe this is consistent with our mission to improve the lives of those around us. Their financial support focuses on initiatives that raise awareness of health issues, which is of central concern to us at Novartis.
Novartis Pharmaceuticals Corporation is taking a leadership position in helping protect our environment for generations to come. The company aim to use natural resources efficiently and minimize the environmental impacts of our activities and products during their lifecycles. See more